Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 10/20 | 0.57 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.54 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.52 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.52 |
| ▸ | TUBB | P07437 | 1/20 | 0.52 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.52 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.52 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.52 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.52 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.52 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.52 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.52 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.52 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.52 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.52 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.52 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.52 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.52 |
| ▸ | GLP1R | P43220 | 4/20 | 0.52 |
| ▸ | CTSL | P07711 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419495 | 0.92 | C5AR1 (0.59) | NPBWR1C5AR1TUBB4ATUBBTUBA3C | |
| SCHEMBL29484172 | 0.92 | C5AR1 (0.59) | NPBWR1C5AR1CXCR4TUBB4ATUBB | |
| SCHEMBL30550555 | 0.91 | TUBB4A (0.55) | NPBWR1C5AR1TUBB4ATUBBTUBA3C | |
| SCHEMBL30861900 | 0.89 | NPBWR1 (0.56) | NPBWR1C5AR1CXCR4CTSLCTSS | |
| SCHEMBL29910876 | 0.89 | NPBWR1 (0.56) | NPBWR1C5AR1CXCR4CTSLCTSS | |
| SCHEMBL30861896 | 0.89 | NPBWR1 (0.56) | NPBWR1C5AR1CXCR4CTSLCTSS | |
| SCHEMBL31473233 | 0.89 | NPBWR1 (0.53) | NPBWR1C5AR1CXCR4TUBB4ATUBB | |
| SCHEMBL31473234 | 0.89 | NPBWR1 (0.53) | NPBWR1C5AR1CXCR4TUBB4ATUBB | |
| SCHEMBL30878115 | 0.89 | GHSR (0.57) | C5AR1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL30518108 | 0.89 | GHSR (0.52) | NPBWR1C5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171776-A1 | NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY | SAREPTA THERAPEUTICS, INC. (US) | 2025-05-29 | — | — | US | claimed |
| US-20250171776-A1 | NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY | SAREPTA THERAPEUTICS, INC. (US) | 2025-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171776-A1 | NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY | MYOF, TNNC1, MTPN | NPBWR1 605/4885C5AR1 704/4885CXCR4 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.